$Mainz Biomed (MYNZ.US)$  presents a significant opportunity for substantial profits, driven by several key catalysts. First, we anticipate an upcoming announcement regarding FDA clearance for a breakthrough device, followed by FDA approval within the next 30 days. This is an opportune moment to consider purchasing shares.

$Mainz Biomed (MYNZ.US)$ FDA usually decides on applications for Breakthrough Devices within 60 days. Thus, the decision should be out by 9 Sept.